SSB
NUVB icon

Sandy Spring Bank’s Nuvation Bio NUVB Stock Holding History

Sandy Spring Bank’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$8.8K Buy
+5,000
New +$11.4K ﹤0.01% 865

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Sandy Spring Bank's NUVB Position: Q1 2025 in Review

Sandy Spring Bank opened a new position in Nuvation Bio (NUVB) in Q1 2025: 5,000 shares worth $8.8K. The stake represents ﹤0.01% of the portfolio and ranks #865 among its holdings.

161 funds tracked by Wall St. Rank hold NUVB as of Q1 2025.

  • Sandy Spring Bank held 5,000 shares of Nuvation Bio worth $8.8K as of Q1 2025.
  • Nuvation Bio was a new Sandy Spring Bank position in Q1 2025.
  • Nuvation Bio made up ﹤0.01% of Sandy Spring Bank's portfolio in Q1 2025, its #865 holding.
  • 161 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.